USE OF LONG PENTRAXIN PTX3 FOR THE TREATMENT OF FGF-8 MEDIATED TUMOUR DISEASES

摘要

The use is described of the long pentraxin PTX3 (PTX3) or one of its functional derivatives as an agent inhibiting the activity of growth factor FGF-8, for the preparation of a medicine for the treatment of tumour diseases associated with abnormal activation of growth factor FGF-8.